相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline
Hanna Jokinen et al.
STROKE (2020)
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan et al.
NEUROLOGY (2019)
Clinical and Biomarker Characteristics According to Clinical Spectrum of Alzheimer's Disease (AD) in the Validation Cohort of Korean Brain Aging Study for the Early Diagnosis and Prediction of AD
Jihye Hwang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
Clifford R. Jack et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework
Clifford R. Jack et al.
JAMA NEUROLOGY (2019)
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
Ingrid S. van Maurik et al.
LANCET NEUROLOGY (2019)
Applying the ATN scheme in a memory clinic population The ABIDE project
Daniele Altomare et al.
NEUROLOGY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment
Urban Ekman et al.
SCIENTIFIC REPORTS (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study
Clifford R. Jack et al.
LANCET NEUROLOGY (2017)
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi et al.
NATURE (2017)
Suspected non Alzheimer's pathology - Is it non-Alzheimer's or non-amyloid?
Melanie Dani et al.
AGEING RESEARCH REVIEWS (2017)
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up
Anders Wallin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Alzheimer's diseasesubcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
Anders Wallin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
Argonde C. van Harten et al.
ALZHEIMERS & DEMENTIA (2013)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2011)
Vascular Disease, Alzheimer's Disease Biomarkers and Cognition in Mild Cognitive Impairment: Additive or Synergetic Effects?
Arto Nordlund et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
Resolving controversies on the path to Alzheimer's therapeutics
Dennis J. Selkoe
NATURE MEDICINE (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Goteborg MCI study:: mild cognitive impairment is a heterogeneous condition
A Nordlund et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
分享论文
